HER2-Low Breast Cancer: Pathological and Clinical Landscape-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HER2-Low Breast Cancer: Pathological and Clinical Landscape

Published:2020-06-10 Issue:17 Volume:38 Page:1951-1962
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Tarantino Paolo¹²,Hamilton Erika³,Tolaney Sara M.⁴,Cortes Javier⁵⁶,Morganti Stefania¹²,Ferraro Emanuela¹²,Marra Antonio¹²,Viale Giulia¹²,Trapani Dario¹²,Cardoso Fatima⁷,Penault-Llorca Frédérique⁸⁹,Viale Giuseppe¹²,Andrè Fabrice¹⁰,Curigliano Giuseppe¹²

Affiliation:

1. European Institute of Oncology IRCCS, Milan, Italy

2. University of Milan, Milan, Italy

3. Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN

4. Dana-Farber Cancer Institute, Boston, MA

5. IOB Institute of Oncology, Quiron Group, Madrid and Barcelona, Spain

6. Vall d’Hebron Institute of Oncology, Barcelona, Spain

7. Breast Unit Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal

8. Jean Perrin Comprehensive Cancer Center, Department of Pathology and Tumor Biology, Centre Jean Perrin, Clermont-Ferrand, France

9. UMR INSERM 1240 IMoST, Université Clermont Auvergne, Villejuif, France

10. Department of Medical Oncology, Gustave Roussy, Villejuif, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.02488

Reference75 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

3. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

4. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

5. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 444 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI-based machine learning radiomics for prediction of HER2 expression status in breast invasive ductal carcinoma;European Journal of Radiology Open;2024-12

2. Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges;Journal of Pathology Informatics;2024-12

3. HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome;European Journal of Cancer;2024-11

4. Understanding the spectrum of HER2 status in breast cancer: From HER2-positive to ultra-low HER2;Pathology - Research and Practice;2024-10

5. Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer;npj Precision Oncology;2024-09-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3